DarioHealth Corp. (NASDAQ:DRIO) headquartered in Caesarea, will host a conference call for the investment community to discuss the 3Q20 financial results on 12th November 2020 at 9:00 AM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.mydario.com
To participate on the live call, please dial 844-369-8770 (United States) or 862-298-0840 Toll Number
Earnings Expectation
DarioHealth Corp. is set to announce third quarter earning results on Thursday 12th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, DRIO to report 3Q20 loss of $ 0.68 per share. For the full year, analysts anticipate top line of $ 7.70 million, while looking forward to loss of $ 4.41 per share bottom line.
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The companys flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. It offers Dario Engage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications; and real time alerts, trends, and pattern analysis.
